Background illustration for clinical trials search

Paid Clinical Trials Atlanta

Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Atlanta GA, Birmingham AL, Knoxville TN, Asheville NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Atlanta GA, Birmingham AL, Memphis TN, Durham NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase 1, Phase 2, Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Newnan GA, Chattanooga TN, Augusta GA, Birmingham AL,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06423911

Phase 3, Recruiting

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

for
Glanzmann Thrombasthenia
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT07136857

Phase 2, Recruiting

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

for
Status Epilepticus
Location: Atlanta GA, Cincinnati OH, Orlando FL, Indianapolis IN,
Sponsor: University of Virginia

Sex: All

Age: 1+

Code: NCT06907173

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

for
Sickle Cell Disease
Location: Atlanta GA, Flowood MS, Columbus OH, Little Rock AR,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07224360

Phase 2, Recruiting

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

for
Sickle Cell Disease Vaso-occlusive Crisis
Location: Atlanta GA, Louisville KY, Cincinnati OH, Greenville NC,
Sponsor: CSL Behring

Sex: All

Age: 12+

Code: NCT06699849

Phase 2, Recruiting

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

for
Acute Myeloid Leukemia Post Cytotoxic Therapy,
Location: Atlanta GA, Birmingham AL, Memphis TN, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT07012044

Phase 1, Recruiting

Quality of End-of-Life Care for Children With Cancer

for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Atlanta GA, Augusta GA, Birmingham AL, Pensacola FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 18+

Code: NCT07412002

Recruiting

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

for
Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma,
Location: Atlanta GA, Birmingham AL, Memphis TN, Durham NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 18

Code: NCT05504291

Phase 2, Recruiting

A Prospective Database of Infants With Cholestasis

for
Biliary Atresia
Location: Atlanta GA, Cincinnati OH, Chicago IL, Philadelphia PA,
Sponsor: Arbor Research Collaborative for Health

Sex: All

Age: 0

Code: NCT00061828

Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Atlanta GA, Macon GA, Chattanooga TN, Greenville SC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

HFNC vs NIPPV Following Extubation

for
Congenital Heart Disease
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 0 - 1

Code: NCT05869825

Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD),
Location: Atlanta GA, Nashville TN, Charlotte NC, Durham NC,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 0+

Code: NCT03394365

Phase 3, Recruiting

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

for
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Location: Atlanta GA, Birmingham AL, Nashville TN, Cincinnati OH,
Sponsor: SeaStar Medical

Sex: All

Age: 0 - 22

Code: NCT06517810

Recruiting

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

for
Persistent Corneal Epithelial Defect
Location: Atlanta GA, Dothan AL, Shelby NC, Nashville TN,
Sponsor: Glaukos Corporation

Sex: All

Age: 2+

Code: NCT05966493

Phase 2, Recruiting

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

for
Cardiovascular Disorder, Classic Hodgkin Lymphoma,
Location: Atlanta GA, Knoxville TN, Pensacola FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 7+

Code: NCT05705531

Recruiting

Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

for
Hemorrhagic Shock, Trauma Injury
Location: Atlanta GA, Wake Forest NC, Memphis TN, Jackson MS,
Sponsor: Philip Spinella

Sex: All

Age: 0 - 17

Code: NCT06070350

Phase 3, Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma,
Location: Atlanta GA, Birmingham AL, Memphis TN, Cincinnati OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT04851119

Phase 1, Phase 2, Recruiting

Treatment of Hemophilia A Patients With FVIII Inhibitors

for
Hemophilia A
Location: Atlanta GA
Sponsor: Emory University

Sex: Male

Age: 0+

Code: NCT04023019

Recruiting